Silence Therapeutics Income Statement (2020-2025) | SLN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.01B	0.01B	0.01B	0.00B	0.00B	0.02B	0.00B	0.00B	0.03B	0.00B	0.00B	0.00B
Cost of Revenue	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Gross Profit	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.01B	-0.00B	-0.00B	0.02B	0.00B	0.00B	0.00B
Operating items
Research & Development	-4.48B	18.05B	-10.28B	-0.01B	-0.01B	0.07B	-0.01B	-0.01B	-0.01B	0.07B	-0.02B	-0.02B	-0.01B	0.10B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B
Selling, General & Administrative	-3.44B	10.35B	-5.17B	-0.01B	-0.01B	0.05B	-0.01B	-0.01B	-0.01B	0.04B	-0.01B	-0.01B	-0.01B	0.05B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Other Operating Expenses															-0.02B	-0.02B			-0.03B	-0.02B
Operating Expenses	-7.92B	28.40B	-15.45B	-0.02B	-0.02B	0.12B	-0.02B	-0.02B	-0.02B	0.12B	-0.02B	-0.02B	-0.02B	0.14B	-0.00B	-0.00B	0.03B	0.03B	0.00B	0.00B	0.03B
Operating Income	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.01B	-0.02B	-0.03B	-0.00B	-0.03B	-0.02B	-0.03B
EBIT	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.01B	-0.02B	-0.03B	-0.00B	-0.03B	-0.02B	-0.03B
Non-operating items
Interest & Investment Income	0.19B	-1.33B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non Operating Income		-0.01B	-0.00B			-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.01B	0.02B	-0.00B	-0.01B	0.00B
Non Operating Income	-0.15B	0.16B	-0.73B	0.74B	-0.00B				-0.00B		-0.00B	-0.00B	-0.00B		0.00B	-0.00B	-0.01B
Net income details
EBT	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.00B	-0.02B	-0.04B	0.01B	-0.03B	-0.03B	-0.02B
Tax Provisions															0.00B	0.00B	0.00B	0.00B		0.00B	0.00B
Profit After Tax	-12.31B	30.15B	-13.61B	-0.02B	-0.02B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	-0.01B	-0.01B	-0.00B	-0.02B	-0.04B	0.01B	-0.03B	-0.03B	-0.02B
Income from Continuing Operations	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.00B	-0.02B	-0.04B	0.01B	-0.03B	-0.03B	-0.02B
Consolidated Net Income	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.00B	-0.02B	-0.04B	0.01B	-0.03B	-0.03B	-0.02B
Income towards Parent Company	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.00B	-0.02B	-0.04B	0.01B	-0.03B	-0.03B	-0.02B
Net Income towards Common Stockholders	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.00B	-0.02B	-0.04B	0.01B	-0.03B	-0.03B	-0.02B
Additional items
EPS (Basic)	-0.16	-0.22	-0.16	-0.21	-0.19	-0.17	-0.14	-0.19	-0.12	-0.16	-0.14	-0.14	-0.12	-0.16	-0.02	-0.14	-0.25	0.09	-0.20	-0.19	-0.15
EPS (Weighted Average and Diluted)										-0.16				-0.13	-0.02	-0.14	-0.25	0.09	-0.20	-0.19	-0.15
Shares Outstanding (Weighted Average)	0.08B	0.08B	0.08B	0.08B	0.09B	0.09B	0.09B	0.09B	0.09B	0.11B	0.11B	0.11B	0.11B	0.12B	0.12B	0.13B	0.14B	0.14B	0.14B	0.14B	0.14B
Shares Outstanding (Diluted Average)										0.11B				0.14B	0.17B	0.18B	0.18B	0.14B	0.14B	0.14B	0.14B
EBITDA	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	0.00B	-0.02B	-0.02B	-0.01B	-0.00B	-0.01B	-0.02B	-0.02B	-0.01B	-0.02B	-0.03B	-0.00B	-0.03B	-0.02B	-0.03B
Tax Rate																		2.57%

Research Tools

Silence Therapeutics Income Statement (2020-2025) | SLN

Create an account

Sign In

Reset Password

Get Pro for 60% off